Albireo Pharma Inc
ALBO
ALBO was delisted on the 2nd of March, 2023.
30 hedge funds and large institutions have $81.8M invested in Albireo Pharma Inc in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 3 closing their positions.
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
50% more capital invested
Capital invested by funds: $54.4M → $81.8M (+$27.3M)
36% more funds holding
Funds holding: 22 → 30 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$12M |
| 2 |
AG
Artal Group
Luxembourg
|
+$7.61M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$2.15M |
| 4 |
Millennium Management
New York
|
+$467K |
| 5 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$287K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.91M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.85M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.43M |
| 4 |
Renaissance Technologies
New York
|
-$375K |
| 5 |
JMH
J.M. Hartwell
New York
|
-$147K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LTFS
26
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
PMFA
27
Plante Moran Financial Advisors
Southfield,
Michigan
| $1K | – | – | – |
|
|
28
Point72 Asset Management
Stamford,
Connecticut
| – | -$3.91M | -186,640 | Closed |
|
|
29
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$1.43M | -68,060 | Closed |
|
30
JP Morgan Chase
New York
| – | -$4K | -200 | Closed |
|
31
Bank of America
Charlotte,
North Carolina
| – | -$1.12K | -44 | -92% |
|
32
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$254 | +10 | New |
|
ALBO Hedge Fund Activity: Q4 2017 in Review
30 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q4 2017, worth a combined $81.8M — up 50% from $54.4M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new ALBO positions and 3 closed out — a net gain of 8 holders — while 9 added to existing stakes and 4 trimmed.
The largest buyer was Perceptive Advisors, adding an estimated $12M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $3.91M sold.
- 30 institutional investors held Albireo Pharma Inc (ALBO) as of Q4 2017, up from 22 in Q3 2017.
- Funds reported $81.8M of Albireo Pharma Inc stock for Q4 2017, up 50% quarter-over-quarter.
- 11 funds opened new Albireo Pharma Inc positions in Q4 2017 and 3 closed out, a net change of +8 holders.
- The largest Albireo Pharma Inc buyer in Q4 2017 was Perceptive Advisors, an estimated $12M added.
- The largest Albireo Pharma Inc seller in Q4 2017 was Point72 Asset Management, an estimated $3.91M sold.
Based on aggregated 13F filings for Q4 2017.